Expression and action of vascular endothelial growth factor and its receptor in a rat model of retinopathy of prematurity

OBJECTIVE: To explore the expression of vascular endothelial growth factor (VEGF) and its receptors (flt-1 and flk-1) in the retina of retinopathy of prematurity (ROP), and its relation to the alteration of retinal blood vessels

Bibliographische Detailangaben
Veröffentlicht in:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 42(2004), 7 vom: 23. Juli, Seite 511-5
1. Verfasser: Luo, Xian-qiong (VerfasserIn)
Weitere Verfasser: Liu, Guo-sheng, Lai, Ri-quan, Nie, Chuan, Wu, Kun-he, Tian, Ye, Xia, Ming-han, Kang, Ju-ling
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Zhonghua er ke za zhi = Chinese journal of pediatrics
Schlagworte:Comparative Study Journal Article Vascular Endothelial Growth Factor A Receptors, Vascular Endothelial Growth Factor EC 2.7.10.1
LEADER 01000naa a22002652 4500
001 NLM150035349
003 DE-627
005 20231223053008.0
007 tu
008 231223s2004 xx ||||| 00| ||chi c
028 5 2 |a pubmed24n0500.xml 
035 |a (DE-627)NLM150035349 
035 |a (NLM)15324569 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Luo, Xian-qiong  |e verfasserin  |4 aut 
245 1 0 |a Expression and action of vascular endothelial growth factor and its receptor in a rat model of retinopathy of prematurity 
264 1 |c 2004 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 02.12.2004 
500 |a Date Revised 24.11.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To explore the expression of vascular endothelial growth factor (VEGF) and its receptors (flt-1 and flk-1) in the retina of retinopathy of prematurity (ROP), and its relation to the alteration of retinal blood vessels 
520 |a METHODS: Eighty-six newborn Sprague-Dawley rats were randomly divided into hyperoxia and air groups, then each group was further divided into 1, 3, 7 and 14 days subgroups. The rats in hyperoxia group inhaled 75% oxygen and ROP model was thus set up. These animals were sacrificed respectively after 1, 3, 7 and 14 days, then the retinal endothelial cells were marked by CD34 to observe the change of retinal blood vessels. The expression of VEGF, flt-1 and flk-1 in the retina was measured by immunohistochemistry 
520 |a RESULTS: The retinal capillary density index (RCDI) in control group increased as days went on (F = 21.589, P < 0.01, but it was the least on the 7th day in hyperoxia group, after the rats had been returned to air for 7 days, RCDI increased significantly (F = 67.885, P < 0.01); In the control group, the expression of VEGF and flk-1 was the strongest in the retina on the 7th day, the result had significant difference as compared with the 1st and 14th day (P < 0.05). The expression of VEGF and flk-1 on the 7th day in hyperoxia group was weaker than that of control group (P < 0.05). But on the 14th day in hyperoxia group, they were stronger than that of control (P < 0.05). The localization of the expression of flt-1 was changed when blood vessels altered, but there was no significant difference in expression intensity as a whole (P > 0.05) 
520 |a CONCLUSION: When the premature retina was exposed to hyperoxia, the expression of VEGF and flk-1 was reduced, and retinal blood vessels were also decreased; but the expression of VEGF and flk-1 was stronger in retina when premature rats were exposed to relative hypoxia, and the retinal blood vessels also increased significantly. It is concluded that VEGF and flk-1 may play important roles in the development of retinal blood vessels and its change in ROP. However, flt-1 has less effect compared with flk-1 
650 4 |a Comparative Study 
650 4 |a Journal Article 
650 7 |a Vascular Endothelial Growth Factor A  |2 NLM 
650 7 |a Receptors, Vascular Endothelial Growth Factor  |2 NLM 
650 7 |a EC 2.7.10.1  |2 NLM 
700 1 |a Liu, Guo-sheng  |e verfasserin  |4 aut 
700 1 |a Lai, Ri-quan  |e verfasserin  |4 aut 
700 1 |a Nie, Chuan  |e verfasserin  |4 aut 
700 1 |a Wu, Kun-he  |e verfasserin  |4 aut 
700 1 |a Tian, Ye  |e verfasserin  |4 aut 
700 1 |a Xia, Ming-han  |e verfasserin  |4 aut 
700 1 |a Kang, Ju-ling  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 42(2004), 7 vom: 23. Juli, Seite 511-5  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnns 
773 1 8 |g volume:42  |g year:2004  |g number:7  |g day:23  |g month:07  |g pages:511-5 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 42  |j 2004  |e 7  |b 23  |c 07  |h 511-5